Originally approved for diabetes management, it has demonstrated substantial weight loss results in clinical trials
Reduces The Risk of Macular (Eye) Degeneration When compared to people with adequate Vitamin B12 levels, those with a deficit have over double the risk of developing AMD, which is a disease of the macula
In the short-term, placebo-controlled trial in adults with schizophrenia, the adverse event of presyncope was reported in 1/167 (0.6%) of patients treated with ABILIFY MAINTENA, while syncope and orthostatic hypotension were each reported in 1/172 (0.6%) of patients treated with placebo
Prescribers should be aware that hydroxocobalamin is contraindicated in patients with a known hypersensitivity to cobalt or any other component of the injection solution
Anyone telling you otherwise about either one has outrun the literature
5-Amino-1MQ is sold as a research chemical and is not approved for human use by any regulatory body